Related Experiment Videos
Establishing SGO's strategic direction for the next millennium. Society of Gynecologic Oncologists
1Department of Gynecologic Oncology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.
Gynecologic Oncology
|August 1, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
MEK inhibitor resistance mechanisms and recent developments in combination trials.
Cancer treatment reviews·2020
Low-grade serous carcinoma of the ovary or peritoneum.
Annals of oncology : official journal of the European Society for Medical Oncology·2016
Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): A review of 47 cases.
Gynecologic oncology·2015
Prognostic factors in malignant ovarian germ cell tumours (The Surveillance, Epidemiology and End Results experience 1978-2010).
European journal of cancer (Oxford, England : 1990)·2014
Tamoxifen is safe and effective in gynecological cancer patients with renal dysfunction.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2007
Systemic anticancer therapy in gynecological cancer patients with renal dysfunction.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2007
Prognostic implications of HPV and TP53 status in early-stage vulvar squamous cell carcinoma.
Gynecologic oncology·2026
Planning and feasibility of phase III surgical trials in gynecologic oncology.
Gynecologic oncology·2026
Programmed cell death in degenerative skeletal diseases: molecular crosstalk and combinatorial therapeutic strategies.
Frontiers in cell and developmental biology·2026
Modeling Risk Group 4 virus infection and antiviral treatment in microfluidic lung organ-on-chips in maximum containment laboratories.
bioRxiv : the preprint server for biology·2026
Orforglipron: An Oral GLP-1 Receptor Agonist for Obesity Treatment.
The Annals of pharmacotherapy·2026
Efficacy and Safety of Tofacitinib Versus Placebo in Patients With Early-Grade Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Trial.
International journal of rheumatic diseases·2026